Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study
Roblin, Xavier, Boschetti, Gilles, Duru, Gérard, Williet, Nicolas, Deltedesco, Emilie, Phelip, Jean M, Peyrin-Biroulet, Laurent, Nancey, Stéphane, Flourié, Bernard, Paul, Stéphane
Published in Inflammatory bowel diseases (01.11.2017)
Published in Inflammatory bowel diseases (01.11.2017)
Get full text
Journal Article
Tu1236 Infliximab Trough Level Thresholds Vary Depending on the Efficacy Criterion Chosen in IBD Patients
Roblin, Xavier, Rinaudo-gaujous, Melanie, Jarlot, Camille, Deltedesco, Emilie, Phelip, Jean Marc, Clavel, Lea, Peyrin-Biroulet, Laurent, Paul, Stephane
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Get full text
Journal Article
Tu1304 Faecal Calprotectin Measurement and Infliximab Trough Levels Predict Therapeutic Evolution CD Patients in Clinical Remission
Roblin, Xavier, Duru, Gerard, Clavel, Lea, Rinaudo-gaujous, Melanie, Deltedesco, Emilie, Cuilleron, Muriel, Jarlot, Camille, Phelip, Jean Marc, Peyrin-Biroulet, Laurent, Paul, Stephane
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Get full text
Journal Article